Cognanous (doing business as Cognano) is a US-based biotech company that leverages alpaca and shark antibody data combined with AI/LLM technology to discover novel biomarkers for drug discovery. The company developed IBMET (Inverse Biomarker Exploring Technology) to identify novel antigens and therapeutic candidates, focusing on biomarker discovery rather than contract manufacturing or drug development services.
VHH antibody biomarker discovery, IBMET technology, AI-driven drug discovery seeds, alpaca/shark antibody databases
1 site worldwide
No certifications on file yet.
No reviews available yet.
No documents available.